AIM
HAE icon

Assured Investment Management’s Haemonetics HAE Stock Holding History

Assured Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-122,612
Closed -$10.7M – 373
2019
Q1 		$10.7M Buy
122,612
+26,127
+27% +$2.38M 0.12% 57
2018
Q4 		$9.65M Buy
96,485
+28,435
+42% +$2.99M 0.27% 72
2018
Q3 		$7.8M Sell
68,050
-99,515
-59% -$10.3M 0.14% 151
2018
Q2 		$15M Buy
167,565
+135,254
+419% +$11.4M 0.28% 65
2018
Q1 		$2.36M Buy
+32,311
New +$2.22M 0.05% 325

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Assured Investment Management's HAE Position: Q2 2019 in Review

Assured Investment Management sold out of Haemonetics (HAE) in Q2 2019, closing a stake of 122,612 shares — an estimated $10.7M sold.

Assured Investment Management first reported a position in HAE in Q1 2018 and held it in 5 quarters. The position peaked at $15M in Q2 2018. 256 funds tracked by Wall St. Rank hold HAE as of Q2 2019.

  • Assured Investment Management reported no remaining Haemonetics position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 122,612 Haemonetics shares in Q2 2019, an estimated $10.7M.
  • Assured Investment Management first reported a position in Haemonetics in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's Haemonetics position peaked at $15M in Q2 2018.
  • 256 funds tracked by Wall St. Rank held Haemonetics as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.